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Background: Severe malarial anaemia (SMA) is a major life-threatening complication of paediatric malaria.
Protracted production of pro-inflammatory cytokines promoting erythrophagocytosis and depressing erythropoiesis
is thought to play an important role in SMA, which is characterized by a high TNF/IL-10 ratio. Whether this
TNF/IL-10 imbalance results from an intrinsic incapacity of SMA patients to produce IL-10 or from an IL-10
unresponsiveness to infection is unknown. Monocytes and T cells are recognized as the main sources of TNF and
IL-10 in vivo, but little is known about the activation status of those cells in SMA patients.
Methods: The IL-10 and TNF production capacity and the activation phenotype of monocytes and T cells were
compared in samples collected from 332 Ghanaian children with non-overlapping SMA (n = 108), cerebral malaria
(CM) (n = 144) or uncomplicated malaria (UM) (n = 80) syndromes. Activation status of monocytes and T cells was
ascertained by measuring HLA-DR+ and/or CD69+ surface expression by flow cytometry. The TNF and IL-10
production was assessed in a whole-blood assay after or not stimulation with lipopolysaccharide (LPS) or
phytohaemaglutinin (PHA) used as surrogate of unspecific monocyte and T cell stimulant. The number of
circulating pigmented monocytes was also determined.
Results: Monocytes and T cells from SMA and CM patients showed similar activation profiles with a comparable
decreased HLA-DR expression on monocytes and increased frequency of CD69+ and HLA-DR+ T cells. In contrast,
the acute-phase IL-10 production was markedly decreased in SMA compared to CM (P= .003) and UM (P= .004).
Although in SMA the IL-10 response to LPS-stimulation was larger in amplitude than in CM (P= .0082), the absolute
levels of IL-10 reached were lower (P= .013). Both the amplitude and levels of TNF produced in response to
LPS-stimulation were larger in SMA than CM (P= .019). In response to PHA-stimulation, absolute levels of IL-10
produced in SMA were lower than in CM (P= .005) contrasting with TNF levels, which were higher (P= .001).
Conclusions: These data reveal that SMA patients have the potential to mount efficient IL-10 responses and that
the TNF/IL-10 imbalance may reflect a specific monocyte and T cell programming/polarization pattern in response
to infection.
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In sub-Saharan Africa, severe malarial anaemia (SMA) is
a frequent complication of Plasmodium falciparum
infections in young children [1] and is one of the main
causes of severe anaemia, with a case-fatality rate reach-
ing 23% in malaria holoendemic areas [2]. Pathogenesis
of SMA is not well understood, although destruction of
the infected erythrocytes accompanied by clearance of
uninfected erythrocytes, erythropoietic suppression and
dyserythropoiesis, can all contribute to anaemia [3,4].
SMA is associated with elevated levels of myelo-
suppressive cytokines, such as TNF, but this is not spe-
cific to the SMA syndrome, as children with cerebral
malaria (CM) also have highly elevated TNF plasma
levels [5]. Previous analysis showed that SMA can be
distinguished from CM on the basis of an elevated ratio
of TNF to its potent anti-inflammatory regulator IL-10
suggesting a central role for the TNF-IL-10 balance in
SMA pathogenesis [5,6]. This is supported by the obser-
vation that anaemia is increased in IL-10 knockout mice
infected with Plasmodium chabaudi [7] and reversed
upon TNF neutralization [7,8].
TNF alone and in concert with multiple other cyto-
kines and chemokines is a potent inhibitor of haemato-
poietic stem cells [9]. Elevated levels of TNF in patients
with chronic inflammation [10], aplastic anaemia [11] or
inherited anaemic disorders [12] have been associated
with inhibition of erythropoiesis. Multiple underlying
mechanisms have been reported, including the caspase-
mediated cleavage of the major erythroid transcription
factor GATA-1 [13], impairment of cell cycle progres-
sion [14], and remodelling of the extracellular matrix
within erythroid niches [15]. The high TNF/IL-10 ratio
characteristic of SMA patients might reflect an insuffi-
cient production of IL-10 in SMA patients to prevent or
counteract the inhibition of erythropoiesis and the in-
crease of erythrophagocytosis induced by TNF and/or to
mitigate other pro-inflammatory stimuli.
Monocytes and T cells are generally recognized as the
main source of TNF and IL-10 in vivo. However, little is
known about their activation status and their contribu-
tion to the TNF/IL-10 imbalance associated with SMA.
Data on monocyte or T cell status in SMA patients are
scarce, although indirect lines of evidence suggest activa-
tion of the monocyte/macrophage compartment in SMA
patients [16-19]. To date, no published study has com-
pared T cell and monocyte status in SMA and CM.
The work reported here sought at investigating
whether children with SMA or CM have distinct TNF
and IL-10 production capacities accounting for their dif-
ferent TNF/IL-10 ratios. To gain insight into the cyto-
kine production capacity and the cellular subsets
involved, Ghanaian children with non-overlapping SMA
or CM syndromes were recruited. Their T cell andmonocyte activation statuses were compared. In
addition, their intrinsic TNF and IL-10 secretion cap-
acity was investigated using whole-blood stimulation
assays with LPS and PHA, used as surrogate of mono-
cyte and T cell stimulant, respectively. Similar analyses
were performed on children with uncomplicated malaria
(UM), considered as a control group for acute malaria
and asymptomatic children (AC) living in the same area,
recruited as a reference group for population baseline.
The data show that the low IL-10 level in SMA cannot
be attributed to a defective IL-10 response capacity and
point to a specific dysregulation. Moreover, the para-
meters investigated provide interesting novel insights
into the distinct inflammatory statuses in SMA and CM.Methods
Study site, patient recruitment and sample collection
Venous blood was collected in sterile heparinised tubes
from children (aged 1–12 years) enrolled at the Depart-
ment of Child Health, Korle-Bu Teaching Hospital,
Accra, during the peak malaria transmission season (July
to August) in 2001 and 2003. Signed informed consent
was obtained from the parents or guardians. The ethics
and protocol review committee of the University of
Ghana Medical School approved the study. Criteria for
patient enrolment and classification have been detailed
elsewhere [20]. Briefly, patients with asexual P. falcip-
arum parasitaemia ≥ 5,000 parasites/μL of blood and ax-
illary temperature > 37.5°C were further categorized into
UM, SMA and CM. UM was defined as full conscious-
ness, haemoglobin (Hb) ≥ 8 g/dL, and no other compli-
cations of malaria. SMA patients had Hb levels < 5 g/dL,
with full consciousness and no other known cause of an-
aemia. CM was defined as unrousable coma with a Blan-
tyre coma score ≤ 3 for more than an hour and without
any sign of other possible causes of coma and Hb
levels ≥ 5 g/dL. Children with a positive sickling test or
any clinical presentation other than malaria were
excluded from the study. Convulsing patients were
excluded from the SMA and UM groups. Patients
included in the study were followed up and blood sam-
ples were taken at 3 and 7 days post admission. Asymp-
tomatic healthy children (AC) were recruited in
Dodowa, a community nearby Accra, from a random
sample of an existing cohort of pre-school and school
children and matched for age and sex with the patients.
Hb concentration and complete blood cell count were
determined using an automated haematology analyzer
(Sysmex). Parasitaemia was determined from Giemsa-
stained thick and thin blood films and expressed as para-
sitized red cells per μL of blood, based on individual
white blood cell counts as described [21]. As the patients
recruited in 2001 and 2003 showed similar clinical,
Boeuf et al. Malaria Journal 2012, 11:253 Page 3 of 9
http://www.malariajournal.com/content/11/1/253haematological and parasitical characteristics, the data
were pooled.Flow cytometry
Monocytes and T cells were identified on the basis of
their forward/side scatter profiles and expression of
CD14 (RM052, Immunotech) and CD3 (SK7, Becton
Dickinson) respectively. Monocyte activation status was
assessed by HLA-DR (L243, Becton Dickinson) surface
expression as described [22]. CD69 (L78, Becton Dickinson)
and HLA-DR expression was used to determine T cell
activation [23]. Staining was conducted on whole blood
using saturating amounts of fluorochrome-conjugated
specific or control antibodies (Becton Dickinson) for
30 minutes at room temperature. Red blood cells were
lysed, and white blood cells washed, fixed in 0.5% for-
maldehyde before acquisition within the next 24 hour
on a FACScan flow cytometer (Becton Dickinson). A
minimum of 5,000 positively-stained events were
acquired. Staining was analysed using CellQuest 3.3 soft-
ware (Becton Dickinson).Whole-blood stimulation
Within four hours after venous blood collection, cyto-
kine production was assessed following a 24-hour incu-
bation of 500 μL of heparinised whole blood with or
without addition of 10 μl of lipopolysaccharide (LPS, E.
coli O111:B4; Sigma-Aldrich) or phytohaemagglutinin
(PHA; Sigma-Aldrich) diluted in RPMI 1640 (Life tech-
nologies, Invitrogen) such that the final concentration
was 100 ng/mL and 2 μg/mL for LPS and PHA respect-
ively. Assays were conducted in polypropylene tubes in
the presence of penicillin and streptomycin at 37°C in
5% CO2. At the end of the incubation period, the sam-
ples were centrifuged and supernatants stored at −80°C
until cytokine assays. IL-10 and TNF levels released in
the supernatant of un-stimulated whole-blood culture
after 24-hour, reflect plasma concentrations at admission
[21] and is referred as the “spontaneous cytokine
secretion”.Cytokine assays
Concentrations of IL-10 and TNF in supernatant from
whole blood assays were quantified in duplicate using
commercially available ELISA kits (BioSource) according
to the manufacturer’s recommendations. Cytokine pro-
duction capacity was calculated as the cytokine concen-
tration measured in the supernatant of LPS or PHA
stimulated whole blood divided by the concentration of
cytokines produced in the un-stimulated condition i.e.
the “spontaneous cytokine production” and reported as
the fold-increase from the un-stimulated condition.Assessment of pigmented monocyte density
Malaria pigment-containing monocyte densities were
determined by counting 30 monocytes on thin films by
an experienced haematologist blinded to clinical presen-
tation and outcome, as described elsewhere [24].
Statistical analyses
Pearson-Chi-square test was used to compare qualitative
data across groups. Quantitative data were compared
across three or more groups by Kruskal-Wallis test,
while the Mann–Whitney test was used for pairwise
comparisons. P values less than .05 were considered sig-
nificant. Associations between different variables were
analysed by Spearman’s rank correlation and considered
statistically significant if r > 0.25 and P < .05.
Results
Clinical, parasitological and haematological characteristics
of malaria patients
The clinical, parasitological and haematological charac-
teristics of the three groups of malaria patients at admis-
sion are shown in Table 1. Age, gender, parasitaemia,
leukocyte and monocyte counts did not differ between
groups. Lymphocyte counts were not significantly differ-
ent in SMA and CM patients and both severe groups
had higher counts than UM patients (P ≤ .0051). As
expected, erythrocyte counts were lower in SMA than in
CM or UM (P ≤ .0001). The percentage of circulating
pigmented monocytes differed between the three groups,
being lower in SMA than in CM (P= .032), but higher
than in UM (P= .039) (Table 1).
SMA and CM cases show a similar transient monocyte
deactivation phenotype independent of the number of
pigmented monocytes
At admission, the percentage of HLA-DR+ monocytes
and the mean fluorescence intensity (MFI) of HLA-DR
expression on monocytes were similar in SMA and CM
patients (P= .99). Both parameters were higher in UM
patients (P ≤ .0001) and did not differ from AC children
(P≥ .56) (Figure 1A and B). The percentages of HLA-DR+
monocytes of SMA (95.9 ± 7.5) and CM (94.6± 11.7)
patients as well as their HLA-DR MFI (SMA:
155.2 ± 114.4; CM: 147.8 ± 77.4) returned to levels
similar to those of AC children 3 days post-admission
(P ≥ .23).
Since haemozoin phagocytosis was shown to decrease
monocyte HLA-DR surface expression [25], the associ-
ation of monocyte HLA-DR expression with the number
of circulating haemozoin-containing (pigmented) mono-
cytes at admission was investigated. In all three clinical
groups, the monocyte HLA-DR MFI was unrelated to
the percentage of pigmented monocytes (SMA: P= .26;
CM: P= .92; UM: P= .69), which did not correlate with
Table 1 Clinical and biological parameters of Patients characteristics
SMA CM UM P value P value
SMA vs. CM (1) SMA vs. CM vs. UM (2)
No. children 108 144 80
Age (years) 3.5 (1–5) 3.1 (1–6) 3.8 (2–6) NSb NSb
Sex [n (%)]
Male 59 (54.6) 78 (54.2) 44 (55) NSa NSa
Female 49 (45.4) 66 (45.8) 36 (45) NSa NSa
Hb (g/dL) 4.3 (3.7-4.7) 6.3 (5–8.02) 9.6 (8.4-10.9) = .0001 ≤ .0001
RBC (109/μL) 1.77 (1.5-2) 2.73 (2.2-3.3) 3.9 (3.6-4.2) = .0001 ≤ .078
WBC (106/μL) 12.1 (8.5-19.1) 11.4 (8.3-15.5) 12.4 (8–15.6) NSb NSb
Lymphocyte(106/μL) 5.3 (2.9-8.1) 3 (1.8-4.8) 1.9 (1.5-3.3) NSb ≤ .0051
Monocytes (106/μL) 0.6 (0.3-1.2) 0.5 (0.2-0.9) 0.7 (0.5-0.9) NSb NSb
Parasitaemia 41322(5060–989003) 52356(5676–1872368) 61000(7396–434024) NSb NSb
HCM (%) 3.3 (0–10) 10 (0–20) 0 (0–3.3) = .032 ≤ .039
Values given are medians numbers (25th-75th percentiles) except when indicated otherwise and for parasitaemia [geometric mean (range)]. CM, SMA, UM and AC
refer to cerebral malaria, severe malarial anaemia, uncomplicated malaria and asymptomatic controls, respectively. HCM=haemozoin-containing monocytes.
(1) Comparison between SMA and CM.
(2) Comparison between the three groups SMA, CM and UM.
a Statistical significance was obtained using the chi-square test.
b Statistical significance was obtained using the using Mann-Whitney’s test (1) or Kruskal-Wallis’ test (2).
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Of note, the number of pigmented monocytes was asso-
ciated neither with parasitaemia nor with Hb
concentration.SMA and CM patients have similar early and late T cell
activation markers expression profiles
Because the time between infection and hospital
admission - and hence duration of the ongoing infection -
may vary across malaria patients, their T cell activation sta-
tus was assessed using early and late T cell activation
markers, namely CD69 and HLA-DR, respectively
(Figure 1C). SMA and CM patients had comparable per-
centages of early and late activated T cells (CD69:
P= .066; HLA-DR: P= .87) and similar T cell MFI for
these markers were observed in both groups (for CD69:
SMA: 26.5 ± 15.6; CM: 21.9 ± 10.4, P= .15 ); for HLA-DR:
SMA: 64.1 ± 42.1; CM: 42.3± 24.6, P= .54). The percen-
tages of early and late activated T cells in SMA or
CM did not differ from UM patients (CD69: P≥ .22;
HLA-DR: P≥ .71). However, malaria patients had higher
percentages of early and late activated T cells than AC
(CD69, P≤ .0001; HLA-DR, P≤ .0003).SMA patients show a lower acute phase IL-10 production
compared to CM patients
IL-10 and TNF levels spontaneously released during a
24-hour un-stimulated whole-blood culture, which re-
flect plasma concentrations at admission [21], showed
much lower IL-10 levels in SMA compared to CM
(P= .003), whereas TNF levels were not different in bothclinical groups (P= .40) (Table 2). Consequently, the
TNF/IL-10 ratio at admission was higher in SMA than
in CM (median = 8.46 [25th percentile = 2.23; 75th per-
centile = 23] vs. 2.13 [0.26-14.6], P= .015). IL-10 levels in
SMA were lower than in UM patients (P= .004) and not
different from those of AC children (P= .45). TNF levels
in SMA and CM were comparable to UM (P= .40), the
lowest levels being in AC children (AC vs. SMA: P= .03;
vs. CM: P= .018; vs. UM: P= .003).
The spontaneous IL-10 production levels correlated
neither with monocyte HLA-DR MFI nor with the per-
centage of pigmented monocytes in each of the SMA,
CM, UM groups or when considering all malaria cases
as a single group (P ≥ .18).SMA patients show a higher IL-10 and TNF monocyte
production capacity than CM cases
In order to determine whether the marked difference in
the spontaneous IL-10 production between SMA and
CM was linked to a monocyte IL-10 production defect,
whole blood LPS stimulation was performed, as it pri-
marily assesses monocyte responses [26]. After 24 hours,
IL-10 levels were measured along with TNF levels
(Table 2) and fold increases from spontaneous levels cal-
culated (Figure 2). After LPS stimulation, IL-10 and
TNF production increased in all groups, including in
SMA patients.
Interestingly, the fold (relative) increase in IL-10
production observed in SMA was higher than in CM
(P= .0082), and not significantly different from the
UM (P= .09) and AC (P= .06) groups (Figure 2).
Figure 1 Monocyte and T cell activation status in the different clinical groups at admission. A. Monocytes were identified based on their
forward (FSC) and side scatter profiles as well as their CD14 positivity (green events). Representative cytograms of monocytes from a UM and a
CM patient are shown. B. The percentages of CD14+ cells (monocytes) positive for HLA-DR were similar between CM and SMA cases and
between UM and AC. However, both CM and SMA cases had higher percentages of HLA-DR+ monocytes than UM or AC children. C. A similar
profile was found for the monocyte HLA-DR mean fluorescence intensity (MFI). D. The percentages of CD3+ cells (T cells) positive for CD69 or
HLA-DR, early and late T cell activation markers, respectively were similar between clinical cases but significantly lower in the AC children.
Percentages were determined at admission for each group. Data are presented as box plots: the box shows the interquartile range, the line
through the box is the median and whiskers indicate the 5th and 95th percentiles. CM, SMA, UM and AC refer to cerebral malaria, severe malarial
anemia, uncomplicated malaria and asymptomatic controls, respectively. * denotes P ≤ .05; ** denotes P ≤ .01; # denotes P> .05.
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stimulation in SMA were lower than in CM (P= .013)
but comparable to UM (P= .52) (Table 2). All malaria
patients produced higher IL-10 absolute levels than
AC (P ≤ .0038).
The fold increase in LPS-stimulated TNF production
was much higher in SMA than in CM (P= .019), UM
(P= .04) or AC (P= .02) (Figure 2) and the absolute TNFTable 2 Spontaneous and stimulated IL-10 and TNF productio
Spontaneous








IL-10 and TNF levels were measured by ELISA in the supernatant of un-stimulated w
described in Methods. Data are presented as median and interquartile range in pg/
uncomplicated malaria and asymptomatic controls, respectively.levels reached after LPS stimulation were much higher
in SMA than in CM (P= .0055) and not significantly dif-
ferent from UM (P= .26) and AC (P= .43) (Table 2).
Low IL-10 T cell response in SMA
To address the possible involvement of T cells in the
specific cytokine imbalance observed in SMA, IL-10 and
TNF levels were measured after stimulation with then in malaria patients
LPS-stimulated PHA-stimulated
188.8 (70–342) 55.3 (30.8-176.6)
623.4 (521.1-1028.25) 608.9 (148.05-725.25)
198.2 (140.6-349.8) 310 (125.3-494.4)
25.8 (5.1-406) 588.4 (434.2-811)
2196 (1595.5-3025.5) 2219 (929.5-3606)
425.6 (217.3-513.7) 876.2 (366.4-1514.5)
1344 (388.2-2461) 1352 (703.7-2534.5)
1265 (544.8-4435) 5857 (2437–9203)
hole-blood (spontaneous production) or after LPS or PHA stimulation as
mL. CM, SMA, UM and AC refer to cerebral malaria, severe malarial anaemia,
Figure 2 IL-10 and TNF production capacity in malaria patients. The IL-10 and TNF production capacity were measured after LPS and PHA
stimulation as described in Methods. Fold increases from spontaneous cytokine secretion i.e. un-stimulated samples are presented as box plots:
the box shows the interquartile range, the line through the box is the median and whiskers indicate the 5th and 95th percentiles. Statistical
significance was determined by Mann–Whitney test. * denotes P ≤ .05; ** denotes P ≤ .01; # denotes P> .05.
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marily T cells, with little activation of monocytes [27].
PHA stimulation increased IL-10 and TNF production
in all four groups of children (Table 2).
The PHA-stimulated fold-increase in IL-10 production
in the SMA group was similar to that of CM (P= .18)
and UM (P= .35), but substantially lower than AC
(P= .0004) (Figure 2). The absolute IL-10 levels reached
after PHA stimulation were lower in SMA than in CM
(P= .0053), UM (P= .036) or AC (P= .0007) (Table 2). In
contrast, the fold-increase in TNF production was
higher in SMA than in CM (P= .01), and similar to UM
(P= .82) (Figure 2). The TNF absolute levels were higher
in SMA than in CM (P= .0008) or UM (P= .036)
(Table 2).
Discussion
The high TNF/IL-10 ratio observed in SMA suggests an
imbalanced production of inflammatory cytokines that
could contribute to anaemia [5,6]. Whether such an im-
balance is an intrinsic characteristic of children with
SMA or reflects a specific response pattern to malaria
infection involving particular cellular sources has pro-
found implications on the design of intervention strat-
egies to prevent SMA. The data reported here show thatSMA patients indeed displayed low spontaneous IL-10
production at admission resulting in higher TNF/IL-10
ratios than CM cases. These findings are consistent with
previous studies in Ghana [5,21], but also more recent
studies in Southern Zambia [28]. Interestingly, in re-
sponse to a monocyte or T cell stimulus IL-10 produc-
tion readily increased in both CM and SMA patients,
but SMA patients were characterized by a much higher
amplitude of the IL-10 and TNF monocyte response to
LPS compared to CM, possibly reflecting different
monocyte priming status. However, the absolute levels
of IL-10 reached after PHA-stimulation remained mod-
est, much lower than for CM or any other group. This
indicates that children experiencing SMA have no inher-
ent incapacity to produce IL-10 and therefore that the
imbalanced cytokine response at admission and upon
further stimulation in vitro likely reflects a specific im-
munological pattern rather than an intrinsic predispos-
ition to a deficient IL10-production.
The data also provide interesting insights into the im-
mune status of children with CM. Although expression
levels of surface activation markers on both lymphocytes
and monocytes were similar in CM and SMA, CM
patients presented a distinct cytokine expression profile,
characterized by spontaneous production of high levels
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duction after monocyte or T cell stimulation, suggesting
an overall relative low-responsiveness to further stimula-
tion. This points to a distinct functional status of circu-
lating T cells and monocytes in SMA and CM, which
both differed from the functional status in UM.
UM children had lower lymphocyte counts, limited
monocyte deactivation, balanced IL-10 and TNF levels
at admission (both lower than CM, IL-10 higher than
SMA) and strong responsiveness to monocyte and T cell
stimulation. Thus, based on analysis of circulating cells,
the three clinical groups had specific response profiles to
the ongoing infection and to further monocyte or T cell
stimulation. IL-10 and TNF responses to a T cell stimu-
lus were higher in AC than in any of the three clinical
malaria groups, suggesting an impaired T cell respon-
siveness in malaria (regardless of the clinical presenta-
tion) as observed by others [29]. Parasite-related factors
may explain the specific IL-10 production profile of
SMA patients. Some studies [30,31] but not others [32]
have found that haemozoin phagocytosis triggered the
production of IL-10 by monocytes and induced a state
of monocyte “anergy/reprogramming” associated with a
deregulated production of pro-inflammatory cytokines
such as TNF [33,34]. However, the lack of association of
IL-10 plasma levels with the number of circulating
haemozoin-containing monocytes observed here, includ-
ing in CM patients who have the highest IL-10 levels,
does not support a direct impact of haemozoin load on
IL-10 production by circulating leukocytes.
There was no significant correlation between the num-
ber of pigmented monocytes and haemoglobin. This
contrast with results from Casals-Pascual et al., although
they found a moderately positive correlation (r2 = 0,29)
[35]. This reflects the unclear relationship between pig-
mented leukocytes and the disease manifestation or the
parasite biomass. The number of circulating pigmented
monocytes depends on a complex clearance kinetics
[36], which may differ depending on whether anaemia is
consecutive to an acute infection or results from a pro-
tracted infection.
CD36-dependent adhesion of infected erythrocytes to
monocytes may modulate the inflammatory cytokine se-
cretion profile, including IL-10 production [37-39] and
the low IL-10 plasma levels in SMA patients may reflect
the low CD36-binding capacity of their infected erythro-
cytes [40]. This is supported by the lower proportion of
haemozoin-containing monocytes in SMA relative to
CM patients, possibly reflecting the reduced phagocyt-
osis of infected erythrocyte subsequent to CD36 binding
[41] but may also merely reflect differences in parasite
biomass.
The discrepant IL-10 levels in SMA and CM could re-
sult from different types or proportions of IL-10producing cells. Recent studies suggest that various sub-
sets of CD4+ T cells including Tr1 and Th1 are import-
ant contributors [42,43]. Compared to CM and UM,
SMA cases produced lower absolute levels of IL-10 but
higher levels of TNF in response to T cell stimulation.
This suggests a T cell functional impairment specific for
IL-10 production in children with SMA. Whether this
reflects an infection-related cytokine expression pro-
gramming or an effector/regulatory T cell subset imbal-
ance is unclear. Additional work is needed to elucidate
this question, especially since depletion of CD4+ T cells
significantly alleviates anaemia in a murine model [44].
Beside T cells, two monocyte subpopulations with dif-
ferent IL-10 producing capacity upon LPS stimulation
are now recognized: the regular CD14brightCD16-/dull
monocytes producing both TNF and IL-10 and the
CD14dim CD16bright monocytes producing high levels of
TNF and little or no IL-10 [45]. Although the latter sub-
set was recently found to be enriched in SMA children
[46], comparable CD14/CD16 cytograms and monocyte
CD14 MFI (CM: 234.1 ± 262.3; SMA: 162 ± 95) and
CD16 MFI (CM: 10.8 ± 12.2; SMA: 13.9 ± 12.1) were
observed here.
A significant but transient down-regulation of HLA-
DR expression of circulating monocytes was observed in
children with severe malaria, irrespective of the clinical
form (SMA or CM). HLA-DR down-regulation has been
described for dendritic cells in Kenyan children with
acute malaria, but was observed in both mild and severe
cases [47]. Phagocytosis of haemozoin and exposure to
IL-10 both induce down-regulation of monocyte HLA-
DR surface expression [25,48]. However, in the CM and
SMA patients studied here, HLA-DR expression was in-
dependent from the number of pigmented monocytes
and did not correlate with circulating IL-10 levels. The
observed HLA-DR down-regulation rather results from
the complex integration of multiple anti-inflammatory
signals, as observed in severe inflammatory syndromes
where it is generally associated with an impaired TNF
production capacity in response to further LPS stimula-
tion [49] reflecting a general cellular reprogramming
phenomenon of acute inflammatory injuries [50-52].
The impaired TNF production after LPS stimulation
observed in CM, but not in SMA, is reminiscent of this
cellular reprogramming and suggests interference be-
tween the monocyte signalling pathway involved in the
overwhelming cytokine production associated with CM
and the LPS-triggered MD2 signalling pathway [53,54].
Thus, CM appears as an acute inflammatory syndrome
with excessive TNF production by monocytes/macrophages
rapidly inducing a high counter-regulatory IL-10 produc-
tion. In contrast, the high TNF levels observed in SMA
would result from a more chronic/sustained production
of TNF maintained by an impaired IL-10 regulatory
Boeuf et al. Malaria Journal 2012, 11:253 Page 8 of 9
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programming state in SMA.
Conclusion
The data reported here point towards a specific pro-
gramming of monocytes and T cells in SMA patients
where low IL-10 levels are not due to intrinsic produc-
tion incapacity but rather to a specific polarization/
programming pathway. Differences in the environmental
context as well as the intensity and duration of malaria-
associated inflammatory stimuli may explain this specific
cytokine response. Directions for future work include
identification of the parasite factors implicated in the
polarization of the immune response and ex vivo dy-
namic functional analysis of specific T cell subsets in
children with CM or SMA. Dissecting the infection-
acquired changes in cytokine expression profiles asso-
ciated with SMA and exploring additional upstream and
downstream mediators as well as cells possibly impli-
cated in dyserythropoiesis or erythrophagocytosis is of
major interest to design intervention strategies.
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